BB Biotech AG Stock
Your prediction
BB Biotech AG Stock
We can see a decrease in the price for BB Biotech AG. Compared to yesterday it has lost -€0.600 (-1.070%).
Pros and Cons of BB Biotech AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BB Biotech AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BB Biotech AG | -1.070% | 5.047% | 8.494% | 65.538% | 15.282% | -4.746% | -4.746% |
| Medpace Holdings Inc | -0.820% | 10.530% | 9.207% | 31.821% | 5.926% | 120.821% | 245.405% |
| Galapagos N.V. | -3.630% | -4.834% | -6.537% | -15.303% | -14.337% | -36.740% | -52.911% |
| United Therapeutics | -0.720% | -0.801% | -3.900% | 78.050% | 7.255% | 105.978% | 195.677% |
Comments
News
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy
EQS-Adhoc: BB Biotech AG publishes its interim report and revises its dividend policy
EQS-News: BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning
EQS-News: BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning


